Clinical Trials Logo

Anxiety Disorders clinical trials

View clinical trials related to Anxiety Disorders.

Filter by:

NCT ID: NCT00643032 Not yet recruiting - Post-Operative Pain Clinical Trials

Preoperative Anxiety and Postoperative Pain in Children

Start date: March 2008
Phase: Phase 4
Study type: Interventional

We wish to study which method of local injection of analgesic (before or during surgery) is the more effective method to reduce post-operative pain in children. In addition, we wish to study which pre-operative educational intervention is more effective in reducing anxiety in children and their family.

NCT ID: NCT00641303 Completed - Breast Cancer Clinical Trials

Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast Cancer

Start date: May 2008
Phase: N/A
Study type: Interventional

RATIONALE: Acupuncture may help relieve muscle and bone pain caused by aromatase inhibitor therapy, such as letrozole, exemestane, and anastrozole. PURPOSE: This randomized phase II trial is studying acupuncture to see how well it works in reducing muscle and bone symptoms in women receiving letrozole, exemestane, or anastrozole for stage 0, stage I, stage II, or stage III breast cancer.

NCT ID: NCT00635999 Completed - Clinical trials for Generalized Anxiety Disorder

A Comparison Between Cognitive, Behavioral, and Cognitive-Behavioral Therapy for Generalized Anxiety Disorder

Start date: October 1991
Phase: N/A
Study type: Interventional

This study will evaluate the effectiveness of three adaptive coping treatments in lessening anxiety in adults with generalized anxiety disorder.

NCT ID: NCT00633984 Completed - Clinical trials for Social Anxiety Disorder

D-Cycloserine Enhancement of Exposure in Social Phobia

Start date: March 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to test a drug called d-cycloserine to see if it can help people with a condition called social phobia. Social phobia is also called "social anxiety disorder." Social phobia is a constant fear of social or performance situations. Social situations include group gatherings of any kind. Performance situations might include times when a person would have to do something in public, such as speak up in class or at a meeting. A person with this condition worries about being embarrassed, or about other people's opinions. People with social phobia usually feel extremely anxious (nervous and worried) about being the focus of attention. They often avoid social and performance situations. This behavior can have a negative effect on the quality of their lives and relationships. In this study, we want to find out if d-cycloserine can help control social phobia when the drug is added to the standard treatment for this condition. The standard treatment is cognitive-behavior therapy (CBT). CBT is a form of talk therapy involving discussion with a therapist, along with practicing the feelings or events that the person finds frightening.

NCT ID: NCT00632983 Active, not recruiting - Prostate Cancer Clinical Trials

Active Surveillance, Radical Prostatectomy, or Radiation Therapy in Treating Patients With Localized Prostate Cancer

Start date: June 2001
Phase: Phase 3
Study type: Interventional

RATIONALE: Radical prostatectomy is surgery to remove the entire prostate. Radiation therapy uses high-energy x-rays or other types of radiation to kill tumor cells. Sometimes the tumor may not need treatment until it progresses. In this case, active surveillance may be sufficient. It is not yet known which treatment regimen is more effective for localized prostate cancer. PURPOSE: This randomized phase III trial is studying active surveillance to see how well it works compared with radical prostatectomy or radiation therapy in treating patients with localized prostate cancer.

NCT ID: NCT00628888 Completed - Depression Clinical Trials

A Waitlist-Controlled Trial of the Unified Protocol for the Treatment of Emotional Disorders in Adolescents

Start date: July 2006
Phase: N/A
Study type: Interventional

This study will evaluate the effectiveness of an emotion-focused cognitive behavioral treatment program for adolescents with anxiety or unipolar depressive disorders.

NCT ID: NCT00624780 Completed - Clinical trials for Generalized Anxiety Disorder

Safety and Efficacy Evaluation Of Pregabalin (Lyrica) With Patients With Generalized Anxiety Disorder

Start date: May 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to characterize the safety and efficacy in patients with generalized anxiety disorder after short- (3 months) and long-term (6 months) use of Pregabalin (Lyrica).

NCT ID: NCT00621270 Completed - Anxiety Clinical Trials

Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety

Start date: January 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether BCI-540 80 mg given once daily (q.d.) or three times daily (t.i.d.) is effective in the treatment of major depression with concomitant anxiety.

NCT ID: NCT00620958 Completed - Anxiety Disorders Clinical Trials

Cognitive Behavioral Therapy With Parental Involvement for Treating Children With Anxiety Disorders

Start date: August 2008
Phase: N/A
Study type: Interventional

This study will compare the effectiveness of individual cognitive behavioral therapy with two distinct types of parent involvement versus individual cognitive behavioral therapy without parent involvement in treating children with anxiety disorders. Hypothesized mediator of change for eac of the two parent treatment conditions also will be evaluated

NCT ID: NCT00620776 Completed - Clinical trials for Generalized Anxiety Disorder

Combined Treatment for Generalized Anxiety Disorder (GAD)

Start date: September 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to conduct a preliminary evaluation of the efficacy of combined medication and psychotherapy for generalized anxiety disorder (GAD). The general goals of the current study are to conduct a late stage treatment development study. The goal of this stage of research is to provide a preliminary answer to the question and to gather data to estimate intervention parameters (e.g., effect size, attrition rates, response rates) that would assist in planning further research.